Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 04, 2010 08:30 ET | Source: Icagen, Inc.

Icagen to Present at the JP Morgan Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Jan. 4, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the 28th Annual JP Morgan Healthcare Conference...
December 01, 2009 08:30 ET | Source: Icagen, Inc.

Icagen to Present at the 63rd Annual Meeting of the American Epilepsy Society

RESEARCH TRIANGLE PARK, N.C., Dec. 1, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that data related to the Company's Phase I program for ICA-105665, the Company's lead drug...
November 13, 2009 16:30 ET | Source: Icagen, Inc.

Icagen Reports Receipt of Notification from NASDAQ Regarding Non-Compliance With Continued Listing Requirements

RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today that on November 12, 2009 the Company received a notification from the NASDAQ Listing...
November 05, 2009 08:15 ET | Source: Icagen, Inc.

Icagen Reports Third Quarter 2009 Financial Results and Operational Highlights

RESEARCH TRIANGLE PARK, N.C., Nov. 5, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the third quarter ended September 30,...
October 26, 2009 16:30 ET | Source: Icagen, Inc.

Icagen Reports Top-line Results of Phase IIa Study of Senicapoc in Exercise-Induced Asthma

RESEARCH TRIANGLE PARK, N.C., Oct. 26, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported that in a proof-of-concept, Phase IIa exercise-induced asthma study, senicapoc failed to...
October 26, 2009 08:15 ET | Source: Icagen, Inc.

Icagen to Report Third Quarter 2009 Results on November 5, 2009

RESEARCH TRIANGLE PARK, N.C., Oct. 26, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release third quarter 2009 financial results on Thursday, November 5, 2009 before...
October 20, 2009 08:15 ET | Source: Icagen, Inc.

Icagen to Present at Eighth Annual Bio Investor Forum

RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the Eighth Annual BIO Investor Forum to be held...
October 19, 2009 16:30 ET | Source: Icagen, Inc.

Icagen Describes Progress in Its Collaboration With Pfizer to Identify Selective Sodium Channel Inhibitors

RESEARCH TRIANGLE PARK, N.C., Oct. 19, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that data related to its collaboration with Pfizer focused on certain sodium channels for the...
September 28, 2009 08:30 ET | Source: Icagen, Inc.

Icagen Announces Initiation of Proof-of-Mechanism Study of ICA-105665 in Pain

RESEARCH TRIANGLE PARK, N.C., Sept. 28, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced the initiation of a proof-of-mechanism study of ICA-105665 for the treatment of pain....
September 24, 2009 08:15 ET | Source: Icagen, Inc.

Icagen Announces Initiation of Proof-of-Concept Study of ICA-105665 in Photosensitive Epilepsy

RESEARCH TRIANGLE PARK, N.C., Sept. 24, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced the initiation of a proof-of-concept study of ICA-105665 in patients with photosensitive...